山东欣博在中国食品药品检定研究院举办的2025年度病理形态学检查能力验证中获“满意-优秀”结果，这是行业对其技术实力与质控水平的高度认可，其规范取材、全面染色及精准分析等技术的严格把控，为验证成功夯实基础，也印证了公司在病理检测领域的专业积淀。

该权威认证标志着山东欣博病理检测专业能力达行业认可标准，其可为准科研机构提供可靠检测数据、为研发企业提供产品安全有效性评价依据，为合作伙伴筑牢技术保障，助力相关工作高效推进。

济南实验室

临邑实验室

Shandong Xinbo's Standardized System and Customized Solutions in Material Technology
Pathological morphology examination serves as the "cornerstone" for precise diagnosis and scientific research validation, with sampling techniques and staining techniques being the two core factors determining the accuracy of the results. In terms of sampling techniques, Shandong Xinbo has long established a comprehensive standardized experimental animal sampling system, ensuring the standardization and stability of basic testing. More notably, Shandong Xinbo has also developed customized specialized sampling solutions tailored to the unique requirements of different experimental scenarios. Whether it is precise sampling for neurovirulence tests in monkeys, accurate collection of skin, muscle, internal organs, bones, and brain tissues related to medical device implants, or meticulous processing of special drug application sites such as the nasal cavity and ears, as well as the efficient preparation of animal tissue chips—all have formed mature and standardized technical processes. These measures effectively mitigate result deviations caused by improper sampling, providing high-quality sample assurance for subsequent testing.

Shandong Xinbo's Comprehensive Technical Reserves Empower Precision Pathological Analysis
In the field of staining technology, Shandong Xinbo also demonstrates comprehensive and professional technical expertise. Beyond conventional HE staining for basic pathological morphology observation, the company has systematically developed histochemical staining techniques capable of precisely locating specific antigens, providing richer molecular-level information for pathological diagnosis. Additionally, for different tissue components and lesion types, it has implemented various specialized chemical staining techniques such as PAS (Periodic Acid-Schiff) staining, Masson's trichrome staining, Mallory's phosphotungstic acid hematoxylin staining, starch staining, toluidine blue staining, and Oil Red O staining. These methods clearly reveal components like glycogen, collagen fibers, nerve fibers, amyloid substances, mucus, and fat, enabling researchers and clinicians to more accurately identify pathological changes. This supports disease mechanism research, drug efficacy evaluation, and the safety verification of medical devices.

Shandong Xinbo's toxic pathological ability has been recognized by CNAS, with technical support for preclinical evaluation
The pathology diagnosis laboratory has obtained the "Toxicity Pathology Examination" capability verification certificate organized by the China National Accreditation Service for Conformity Assessment, marking that Shandong Xinbo Pharmaceutical Research Co., Ltd.'s professional ability in toxicity pathology diagnosis has been recognized by the China National Accreditation Service for Conformity Assessment, and the test report issued has authority and credibility.

Shandong Xinbo was established in April 2010, with Jinan Laboratory and Linyi Laboratory. It is a national high-tech enterprise, Shandong Enterprise Technology Center, Shandong Gazelle Enterprise, and a research service-oriented enterprise that integrates pharmacological research, toxicology research, drug analysis and testing services, animal pathology testing, and medical device evaluation services. We have completed preclinical safety evaluations for over 400 innovative drugs, including chemical drugs, traditional Chinese medicine and natural medicines, biological products, preventive and therapeutic vaccines, monoclonal antibodies, cell therapy products, medical devices, and other varieties.